Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System
Mölndal, Sweden – June 13, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a Memorandum of Understanding with the American medtech company Coapt LLC, with the intention to provide Integrum the possibility to combine Coapt’s pattern recognition technology with the continued development of e-OPRA[TM] Implant System.Coapt is the leading developer of advanced control solutions for prosthetics. Their primary product is a pattern recognition intent decoder system, called Complete Control, designed to enhance the functionality and user